Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

CUSIP: 08205P209

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
35,393,481
Total 13F shares
1,270,837
Share change
+73,222
Total reported value
$6,576,960
Price per share
$5.25
Number of holders
13
Value change
+$379,920
Number of buys
4
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) as of Q1 2024

As of 31 Mar 2024, Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,270,837 shares. The largest 10 holders included FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, GAMMA Investing LLC, Tower Research Capital LLC (TRC), and UBS Group AG. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.